Your browser doesn't support javascript.
loading
Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma.
Aoki, Tomohiro; Chong, Lauren C; Takata, Katsuyoshi; Milne, Katy; Hav, Monirath; Colombo, Anthony; Chavez, Elizabeth A; Nissen, Michael; Wang, Xuehai; Miyata-Takata, Tomoko; Lam, Vivian; Viganò, Elena; Woolcock, Bruce W; Telenius, Adèle; Li, Michael Y; Healy, Shannon; Ghesquiere, Chanel; Kos, Daniel; Goodyear, Talia; Veldman, Johanna; Zhang, Allen W; Kim, Jubin; Saberi, Saeed; Ding, Jiarui; Farinha, Pedro; Weng, Andrew P; Savage, Kerry J; Scott, David W; Krystal, Gerald; Nelson, Brad H; Mottok, Anja; Merchant, Akil; Shah, Sohrab P; Steidl, Christian.
Afiliación
  • Aoki T; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada.
  • Chong LC; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Takata K; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada.
  • Milne K; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada.
  • Hav M; Deeley Research Centre, British Columbia Cancer, Vancouver, British Columbia, Canada.
  • Colombo A; Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.
  • Chavez EA; Cedars-Sinai Medical Center, Los Angeles, California.
  • Nissen M; Cedars-Sinai Medical Center, Los Angeles, California.
  • Wang X; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada.
  • Miyata-Takata T; Terry Fox Laboratory, British Columbia Cancer, Vancouver, British Columbia, Canada.
  • Lam V; Terry Fox Laboratory, British Columbia Cancer, Vancouver, British Columbia, Canada.
  • Viganò E; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada.
  • Woolcock BW; Terry Fox Laboratory, British Columbia Cancer, Vancouver, British Columbia, Canada.
  • Telenius A; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada.
  • Li MY; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Healy S; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada.
  • Ghesquiere C; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada.
  • Kos D; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada.
  • Goodyear T; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Veldman J; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada.
  • Zhang AW; Deeley Research Centre, British Columbia Cancer, Vancouver, British Columbia, Canada.
  • Kim J; Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.
  • Saberi S; Deeley Research Centre, British Columbia Cancer, Vancouver, British Columbia, Canada.
  • Ding J; Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.
  • Farinha P; Deeley Research Centre, British Columbia Cancer, Vancouver, British Columbia, Canada.
  • Weng AP; Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.
  • Savage KJ; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Scott DW; Department of Molecular Oncology, British Columbia Cancer, Vancouver, British Columbia, Canada.
  • Krystal G; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Nelson BH; Terry Fox Laboratory, British Columbia Cancer, Vancouver, British Columbia, Canada.
  • Mottok A; Department of Molecular Oncology, British Columbia Cancer, Vancouver, British Columbia, Canada.
  • Merchant A; Department of Molecular Oncology, British Columbia Cancer, Vancouver, British Columbia, Canada.
  • Shah SP; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Steidl C; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada.
Cancer Discov ; 10(3): 406-421, 2020 03.
Article en En | MEDLINE | ID: mdl-31857391
Hodgkin lymphoma is characterized by an extensively dominant tumor microenvironment (TME) composed of different types of noncancerous immune cells with rare malignant cells. Characterization of the cellular components and their spatial relationship is crucial to understanding cross-talk and therapeutic targeting in the TME. We performed single-cell RNA sequencing of more than 127,000 cells from 22 Hodgkin lymphoma tissue specimens and 5 reactive lymph nodes, profiling for the first time the phenotype of the Hodgkin lymphoma-specific immune microenvironment at single-cell resolution. Single-cell expression profiling identified a novel Hodgkin lymphoma-associated subset of T cells with prominent expression of the inhibitory receptor LAG3, and functional analyses established this LAG3+ T-cell population as a mediator of immunosuppression. Multiplexed spatial assessment of immune cells in the microenvironment also revealed increased LAG3+ T cells in the direct vicinity of MHC class II-deficient tumor cells. Our findings provide novel insights into TME biology and suggest new approaches to immune-checkpoint targeting in Hodgkin lymphoma. SIGNIFICANCE: We provide detailed functional and spatial characteristics of immune cells in classic Hodgkin lymphoma at single-cell resolution. Specifically, we identified a regulatory T-cell-like immunosuppressive subset of LAG3+ T cells contributing to the immune-escape phenotype. Our insights aid in the development of novel biomarkers and combination treatment strategies targeting immune checkpoints.See related commentary by Fisher and Oh, p. 342.This article is highlighted in the In This Issue feature, p. 327.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Asunto principal: Enfermedad de Hodgkin / Análisis de la Célula Individual / Microambiente Tumoral / Transcriptoma Límite: Female / Humans / Male Idioma: En Revista: Cancer discov Año: 2020 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Asunto principal: Enfermedad de Hodgkin / Análisis de la Célula Individual / Microambiente Tumoral / Transcriptoma Límite: Female / Humans / Male Idioma: En Revista: Cancer discov Año: 2020 Tipo del documento: Article País de afiliación: Canadá